secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001730463-23-000106
Event type: regulatory
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus voluntarily elects U.S. domestic issuer reporting, no change to Q3 2023 financials
--------------------------------------------------------------------------------

- Autolus will file periodic reports on Forms 10-K, 10-Q, and 8-K instead of foreign private issuer forms.
- No financial or disclosure changes from the Form 6-K filed on November 2, 2023 for the quarter ended September 30, 2023.
- Company retains foreign private issuer status, exempt from U.S. proxy rules, Regulation FD, and Section 16.
- Effective immediately; first U.S. domestic issuer report to be filed later today (Q3 2023 Form 10-Q).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000173046323000106/0001730463-23-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000173046323000106/autl-20231109.htm
  HTML page:      https://secwatch.observer/filing/0001730463-23-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer